Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0622503B2 - Translucent living body terminal - Google Patents
[go: Go Back, main page]

JPH0622503B2 - Translucent living body terminal - Google Patents

Translucent living body terminal

Info

Publication number
JPH0622503B2
JPH0622503B2 JP61140240A JP14024086A JPH0622503B2 JP H0622503 B2 JPH0622503 B2 JP H0622503B2 JP 61140240 A JP61140240 A JP 61140240A JP 14024086 A JP14024086 A JP 14024086A JP H0622503 B2 JPH0622503 B2 JP H0622503B2
Authority
JP
Japan
Prior art keywords
translucent
terminal
living body
calcium phosphate
body terminal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61140240A
Other languages
Japanese (ja)
Other versions
JPS62298348A (en
Inventor
秀希 青木
勝 赤尾
美治 秦
正章 東方
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advance KK
Original Assignee
Advance KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advance KK filed Critical Advance KK
Priority to JP61140240A priority Critical patent/JPH0622503B2/en
Publication of JPS62298348A publication Critical patent/JPS62298348A/en
Publication of JPH0622503B2 publication Critical patent/JPH0622503B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Endoscopes (AREA)

Description

【発明の詳細な説明】 本発明はその外周部がアルミナ、ハイドロキシアパタイ
ト等、皮膚との親和性にすぐれた部材より成り、中心の
一部又は全部が透光性及び生体親和性にすぐれた部材よ
り成る透光性生体端子に関する。
DETAILED DESCRIPTION OF THE INVENTION In the present invention, the outer peripheral portion is made of a material such as alumina or hydroxyapatite having excellent affinity with the skin, and a part or all of the center thereof is excellent in translucency and biocompatibility. And a translucent biometric terminal.

近時、骨、生体内組織に対して為害性のない材料を用
い、人工骨を形成したり、或いは人工臓器の表面に上記
材料を被覆することによって長期間の埋入が具現化され
つつあり、人工材料の生体内依存度が年々高くなりつつ
ある。
Recently, long-term implantation has been realized by forming artificial bones by using materials that are not harmful to bones and in vivo tissues, or by coating the surface of artificial organs with the above materials. , The dependence of artificial materials on the body is increasing year by year.

しかしながら、これらの人工材料が確かに生体組織に為
害性がないものであることは、現在では実証することが
むずかしく、長期的インプラントの組織反応の経過は未
だ解明されるに至っていない。長期的な組織反応を観察
する方法としては、体内より体液等や組織を取り出す
か、X線、超音波等によって観察する方法しかなく、体
内から体液や組織を取り出す為には、患者の苦痛等から
連続的観察は不可能に近く、X線、超音波等において
は、その分解能において細かい部分の観察や組織的反応
の観察は到底不可能である。
However, it is difficult to demonstrate that these artificial materials are not harmful to living tissues, and the course of the tissue reaction of long-term implants has not yet been elucidated. The only method for observing a long-term tissue reaction is to remove body fluid or tissue from the body or to observe it with X-rays or ultrasonic waves. Therefore, continuous observation is almost impossible, and with X-rays, ultrasonic waves, etc., it is impossible to observe a fine portion or a systematic reaction due to its resolution.

このように生体内情報の測定は上記人工材料と生体組織
との反応のみならず、血液組成、体液成分の測定におい
ても同様に連続的には行なえるものではない。
Thus, the measurement of in-vivo information cannot be continuously performed not only in the reaction between the artificial material and the biological tissue but also in the measurement of blood composition and body fluid components.

上記に鑑み本発明者らは鋭意研究の結果、生体親和性に
秀れているのみならず、光と透過性が高いリン酸カルシ
ウム系セラミックス材或いはアルミナセラミックス材を
用いて生体内外を光学的に連結した所、長期的に生体内
情報、特に視覚的観察が行なえることを知見し本発明に
到達したものである。
In view of the above, the inventors of the present invention have diligently studied, and not only excel in biocompatibility but also optically couple the inside and outside of the body using a calcium phosphate-based ceramics material or an alumina ceramics material having high light and light transmittance. The present inventors have arrived at the present invention by finding that in-vivo information, particularly visual observation, can be performed for a long period of time.

以下、本発明透光性生体端子につき、その材料組成、形
状乃至構造につき詳細に説明する。
Hereinafter, the material composition, shape and structure of the translucent biological terminal of the present invention will be described in detail.

材料組成・製法 本発明に於ける“リン酸カルシウム系セラミックス材”
とは、下記のようである。
Material composition and manufacturing method "Calcium phosphate ceramics material" in the present invention
Is as follows.

Ca10(PO4)6(OH)2で表わされるハイドロキスアパタイ
ト。Ca10(PO4)6(OH)2で表わされる純粋品のみならず、O
Hイオンのかわりに1〜10%のカーボネート(CO3)イオン
やフッ素、塩素イオンを含むもの。Ca10(PO4)6(OH)2
主成分とするも焼結性、強度、細孔度等を向上すべく、
これにCa3(PO4)2,MgO, Na2O, K2O, CaF2, Al2O3, SiO2,
CaO, Fe2O3, MnO, MnO2, ZnO, C, SrO, PbO, BaO, TiO
2, ZrO2等々の周知各種添加剤を添加混合したもの。比
較的毒性の少ないポリエチレン、ポリプロピレン、ポリ
メチルメタクリレート、ポリウレタン、ポリエステル、
ABS,フッ素、ポリカーボネート、ポリスルホン、エ
ポキシ、シリコーン、ジアリルフタレート、フラン等の
高分子樹脂との複合剤。Ca/Pモル比が1.0〜2.0であるリ
ン酸三カルシウム、リン酸四カルシウム、或いはバイオ
ガラス、リン酸カルシウム系結晶化ガラス等を例示する
ものである。又、アルミナセラミックスは、パイヤー法
等で製造された二次粒子を粉砕しα−アルミナ結晶を生
成、金型プレスス成形後、1600〜1700℃で焼結して成
る。
Hydroxyapatite represented by Ca 10 (PO 4 ) 6 (OH) 2 . Not only the pure product represented by Ca 10 (PO 4 ) 6 (OH) 2 but also O
Those containing 1 to 10% of carbonate (CO 3 ) ions, fluorine and chlorine ions instead of H ions. Ca 10 (PO 4 ) 6 (OH) 2 as a main component, in order to improve sinterability, strength, porosity, etc.
This Ca 3 (PO 4) 2, MgO, Na 2 O, K 2 O, CaF 2, Al 2 O 3, SiO 2,
CaO, Fe 2 O 3 , MnO, MnO 2 , ZnO, C, SrO, PbO, BaO, TiO
A mixture of various well-known additives such as 2 , ZrO 2 . Relatively less toxic polyethylene, polypropylene, polymethylmethacrylate, polyurethane, polyester,
Compounding agent with polymer resin such as ABS, fluorine, polycarbonate, polysulfone, epoxy, silicone, diallyl phthalate, furan. Examples include tricalcium phosphate, tetracalcium phosphate having a Ca / P molar ratio of 1.0 to 2.0, bioglass, and calcium phosphate-based crystallized glass. Alumina ceramics is formed by crushing secondary particles produced by the Payer method or the like to form α-alumina crystals, press-molding with a die, and sintering at 1600 to 1700 ° C.

尚、上記材料組成を主成分とするも焼結性、強度、細孔
度等を向上すべく、これに各種高分子材料の周知各種添
加剤を添加混合したものをも包含する。
It should be noted that it also includes those containing the above-mentioned material composition as a main component, and mixed with well-known various additives of various polymer materials in order to improve sinterability, strength, porosity and the like.

ここで、高分子との複合剤とする場合は、比較的毒性の
少ないポリエチレン、ポリプロピレン、ポリメチルメタ
クリレート、ポリウレタン、ボリエステル、ABS樹
脂、フッ素樹脂、ポリカーボネート、ポリスルホン、エ
ポキシ樹脂、シリコン樹脂、ジアリルフタレート樹脂、
フラン樹脂等の樹脂を選ぶことができる。
Here, when it is used as a composite agent with a polymer, polyethylene, polypropylene, polymethyl methacrylate, polyurethane, polyester, ABS resin, fluororesin, polycarbonate, polysulfone, epoxy resin, silicone resin, diallyl phthalate resin, which is relatively less toxic ,
A resin such as furan resin can be selected.

透光性部材 本発明に於ける“透光性部材”とは、ガラスファイバ
ー、プラスチックスファイバー等を含む光学的・機械的
接続、更には生体親和性を秀れたバイオガラスセラミッ
クス、リン酸カルシウム系結晶化ガラス、透光性アパタ
イト、単結晶アルミナ、シリコーンゴム、テフロン、ポ
リウレタン等の透光性ポリマーを例示し得る。又、前記
リン酸カルシウム系セラミックス材をガラス化せしたも
のも包含するもので、例えば透光性アパタイトは、ハイ
ドロキシアパタイト粉末を真空度10-3〜10-5torrの空間
において、圧力500〜2000kg/cm2で500〜1300℃の焼結を
施すホットプレス法等により生成される。
Translucent member In the present invention, the "translucent member" means optical / mechanical connection including glass fiber, plastics fiber, etc., and further bio-glass ceramics excellent in biocompatibility, calcium phosphate-based crystal. Illustrative examples include translucent polymers such as synthetic glass, translucent apatite, single crystal alumina, silicone rubber, Teflon and polyurethane. In addition, it also includes those obtained by vitrifying the calcium phosphate ceramics material, for example, translucent apatite, hydroxyapatite powder in a space of vacuum degree 10 -3 -10 -5 torr, pressure 500 ~ 2000 kg / cm. 2 is produced by a hot pressing method or the like in which sintering is performed at 500 to 1300 ° C.

該透光性アパタイトは、透過性を有するのみならず生体
親和性を供えているものであるから、透光性アパタイト
のみによって成形されたものでも本発明にそぐうもので
ある。更に透光性アパタイトに加え、3CaO・P2O5−CaO・S
iO2−CaO・MgO・2SiO2系のガラスにCaF2を添加した組成
のガラスを作成した後結晶化したリン酸カルシウム系結
晶化ガラスについても同様である。
Since the translucent apatite not only has transmissivity but also has biocompatibility, a product formed only from the translucent apatite is also suitable for the present invention. In addition to translucent apatite, 3CaO ・ P 2 O 5 -CaO ・ S
The same applies to the calcium phosphate-based crystallized glass that is crystallized after the glass having the composition in which CaF 2 is added to the iO 2 —CaO · MgO · 2SiO 2 based glass is prepared.

尚、詳しくは特公昭55−11625に記載のリン酸カルシウ
ム系結晶化ガラスの製法を参考とするものである。
For details, refer to the method for producing a calcium phosphate-based crystallized glass described in JP-B-55-11625.

形状乃至構造 本発明生体端子形態は使用目的に応じて所望のものとな
し得るが、その典型例につき添付図面を参照して詳説す
れば次に通りである。
Shape or Structure The bio-terminal configuration of the present invention may be desired according to the purpose of use, but a typical example thereof will be described in detail with reference to the accompanying drawings.

すなわち、第1図は本発明生体端子の1例を示す断面図
であり、図中生体端子はハイドロキシアパタイト焼結体
より成るものであり、その中心部に、外部からに透光性
に優れた透光性アパタイト1が埋設されている。
That is, FIG. 1 is a cross-sectional view showing an example of the biomedical terminal of the present invention, in which the biomedical terminal is made of a hydroxyapatite sintered body, and its central portion is excellent in transparency from the outside. The translucent apatite 1 is embedded.

上記構造の生体端子は端子底部を皮下に埋設固定し、端
子頭部2の上端部を皮上に突出配置して使用されるもの
であり、生体内物質の赤外線吸収スペクトル測定や内視
鏡として利用される。
The biological terminal of the above structure is used by embedding and fixing the bottom of the terminal under the skin and projecting the upper end of the terminal head 2 onto the skin. Used.

同じく第2図は、透光性アパタイトが端子底部のみに埋
設されていることを除いては前記例と同一構成を有す
る。
Similarly, FIG. 2 has the same structure as the above example except that the translucent apatite is embedded only in the bottom of the terminal.

又、第3図は、生体端子全体が透光性アパタイトから形
成されている。
Further, in FIG. 3, the entire biometric terminal is formed of translucent apatite.

第4図は、第3図の生体端子の要部をハイドロキシアパ
タイト焼結被覆材(特開昭52−82893号、同53−75209号
及び同53−118411号公報等参照)で形成したことを示
す。
FIG. 4 shows that the main part of the biomedical terminal shown in FIG. 3 is formed of a hydroxyapatite sintered coating material (see Japanese Unexamined Patent Publication Nos. 52-82893, 53-75209, 53-118411, etc.). Show.

第5図は、光通信用光ファイバー或いはレーザー光伝送
用の光ファイバー等の透光性部材表面にリン酸カルシウ
ム系セラミックス材を被覆せしめたものである。第6図
は、光通信用光ファイバーの表面にシリコーン樹脂等に
より一次被覆を行なった等の透光性部材にリン酸カルシ
ウム系セラミックス材を被覆或いは設けたものである。
FIG. 5 shows a surface of a transparent member such as an optical fiber for optical communication or an optical fiber for transmitting laser light, which is coated with a calcium phosphate ceramics material. FIG. 6 shows a case where a calcium phosphate ceramics material is coated or provided on a translucent member such as a surface of the optical fiber for optical communication which is primarily coated with silicone resin or the like.

第5図乃至第6図は、光ファイバーによって映像装置と
記憶装置等との光学的連結を行なう等、生体深部の直接
的観察を可能とするものである。
FIG. 5 to FIG. 6 enable direct observation of a deep part of a living body by optically connecting an imaging device and a storage device or the like with an optical fiber.

以下、本発明を実験例により詳細に説明する。Hereinafter, the present invention will be described in detail with reference to experimental examples.

実験例1 1.透光性生体端子の製造 ハイドロキシアパタイト粉末は、0.5モル/水酸化カ
ウシウムと0.3モル/リン酸溶液を徐々に滴下し、37
℃で1日反応させて合成し、これを濾過乾燥して得た。
この合成粉末30gを内径30mmの金型に充填し、これを真
空度10-4torr、圧力900kg/cm2の密閉空間中で1100℃で
1時間焼結処理せしめて、圧縮強度1000kg/cm2、相対密
度99%の透光性を有するハイドロキシアパタイト焼結体
を得た。これを超音波加工機及び歯科用ダイヤモンドバ
ーにより、第3図に示した形状からなる生体端子を得
た。
Experimental Example 1 1. Manufacture of translucent bio-terminals Hydroxyapatite powder is 0.5 mol / causium hydroxide and 0.3 mol / phosphoric acid solution slowly dropped,
The reaction was carried out at 0 ° C for 1 day to synthesize, and this was obtained by filtration and drying.
30 g of this synthetic powder was filled in a mold with an inner diameter of 30 mm, and this was sintered for 1 hour at 1100 ° C. in a closed space with a vacuum degree of 10 -4 torr and a pressure of 900 kg / cm 2 , and a compression strength of 1000 kg / cm 2 A hydroxyapatite sintered body having a relative density of 99% and a light-transmitting property was obtained. An ultrasonic processing machine and a dental diamond bar were used to obtain a biometric terminal having the shape shown in FIG.

ここに於いて、端子底部は直径24mm、厚さ3mm、端子頭
部首部分の平均径は6mmである。
Here, the terminal bottom has a diameter of 24 mm, a thickness of 3 mm, and the terminal head neck has an average diameter of 6 mm.

2.動物実験 上記生体端子を雑種成犬の側腹部皮膚に埋設し、経時観
察した結果、端子は底部及び首部分に於いて術後2週目
で皮膚組織と強く結合接着して引っ張っても取れない状
態となり、1年経過後でも肉眼的に炎症反応などの異常
所見は何ら認められなかった。
2. Animal experiment The above-mentioned living body terminal was embedded in the flank skin of a mongrel dog and observed over time. As a result, the terminal was strongly bonded and adhered to the skin tissue at the bottom and neck 2 weeks after the operation, and could not be removed even if pulled. After a lapse of one year, no abnormal findings such as inflammatory reaction were visually observed.

また、通常の組織学的検索でも炎症細胞などは認められ
なかった。
In addition, no inflammatory cells were found in the usual histological examination.

実験例2 アルミナ(Al2O3)粉砕機で微粉砕した粉末(粒径5μ
m)を光通信用石英系光ファイバー素線(直径1mm)を
表面にプラズマガン(メテコ社製9MB)を用いてプラズ
マ溶射を施し、添付第5図に図示する形状の端子を得
た。この端子の溶射部分の長さは10mm、最大径1mmであ
った。
Experimental Example 2 Powder finely pulverized with an alumina (Al 2 O 3 ) pulverizer (particle size 5 μ
m) was plasma-sprayed on the surface of a silica optical fiber wire (diameter 1 mm) for optical communication using a plasma gun (9 MB manufactured by Meteco Co., Ltd.) to obtain a terminal having the shape shown in the attached FIG. The length of the sprayed portion of this terminal was 10 mm, and the maximum diameter was 1 mm.

次にこれを成犬胸部に所定個数その先端が皮下に位置す
るように刺通埋設した処、約3週後には皮膚組織と完全
に結合、固定された状態となった。
Next, a predetermined number of these were pierced and embedded in the chest of an adult dog so that the tips thereof were located subcutaneously, and after about 3 weeks, they were completely bonded and fixed to the skin tissue.

そこで、端子金線を心電計に接続、測定した結果、皮膚
インピーダンスやアーチファクトによる影響が完全に排
除された極めて鮮明な心電図が得られた。
Therefore, as a result of connecting and measuring the terminal gold wire to an electrocardiograph, an extremely clear electrocardiogram was obtained in which the effects of skin impedance and artifacts were completely eliminated.

【図面の簡単な説明】[Brief description of drawings]

添付第1図乃至第6図は本発明生体端子の模式断面図で
ある。 1……透光性部材、2……端子頭部、 3……端子底部、4……光ファイバー、 5……ハイドロキシアパタイト、 6……アルミナ、7……一次被覆層。
FIGS. 1 to 6 attached herewith are schematic cross-sectional views of the biological terminal of the present invention. 1 ... Translucent member, 2 ... Terminal head, 3 ... Terminal bottom, 4 ... Optical fiber, 5 ... Hydroxyapatite, 6 ... Alumina, 7 ... Primary coating layer.

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】少なくとも皮膚組織との接触部分がリン酸
カルシウム系セラミックス部材より成り、且つ生体内外
を光学的に連結する透光性部材を有することを特徴とす
る透光性生体端子。
1. A translucent biomedical terminal, characterized in that at least a portion in contact with skin tissue is made of a calcium phosphate ceramics member, and has a translucent member for optically connecting the inside and outside of the living body.
【請求項2】少なくとも皮膚組織との接触部分がアルミ
ナセラミックス部材より成り、且つ生体内外を光学的に
連結する透光性部材を有することを特徴とする透光性生
体端子。
2. A translucent biomedical terminal, characterized in that at least a contact portion with the skin tissue is made of an alumina ceramics member and has a translucent member for optically connecting the inside and outside of the living body.
JP61140240A 1986-06-18 1986-06-18 Translucent living body terminal Expired - Lifetime JPH0622503B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP61140240A JPH0622503B2 (en) 1986-06-18 1986-06-18 Translucent living body terminal

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61140240A JPH0622503B2 (en) 1986-06-18 1986-06-18 Translucent living body terminal

Publications (2)

Publication Number Publication Date
JPS62298348A JPS62298348A (en) 1987-12-25
JPH0622503B2 true JPH0622503B2 (en) 1994-03-30

Family

ID=15264167

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61140240A Expired - Lifetime JPH0622503B2 (en) 1986-06-18 1986-06-18 Translucent living body terminal

Country Status (1)

Country Link
JP (1) JPH0622503B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2787828B2 (en) * 1988-04-06 1998-08-20 株式会社アドバンス Translucent biological terminal
JPH01267443A (en) * 1988-04-19 1989-10-25 Mitsubishi Kasei Corp Optical measurement method and device

Also Published As

Publication number Publication date
JPS62298348A (en) 1987-12-25

Similar Documents

Publication Publication Date Title
Orlovskii et al. Hydroxyapatite and hydroxyapatite-based ceramics
Prakasam et al. Fabrication, properties and applications of dense hydroxyapatite: a review
DE69024647D1 (en) COMPOSITE-CERAMIC MATERIAL AND METHOD FOR PRODUCTION
Mirdamadi et al. Metal oxide-based ceramics
JPH0622503B2 (en) Translucent living body terminal
Sen et al. Standards of mechanical, physical, chemical, and biological properties of bioceramics
Vlasov et al. Ceramics and medicine
KR100508474B1 (en) Method for preparing porous implant and it's material thereof
JP2787828B2 (en) Translucent biological terminal
Hoque et al. Structural, Chemical, Electrical, Thermal, and Mechanical Properties of Bioceramics
JP4543152B2 (en) Transparent titanium-coated biocompatible material
JPS6179463A (en) Composite apatite artificial bone material
EP3156082B1 (en) Production of monticellite (camgsio4) based bioactive ceramics from boron waste
JPS633833A (en) Endoscopic member for living body
Jones Ceramic biomaterials
Sen et al. 14 Standards of Mechanical, Physical, Chemical, and Biological Properties
JPS6335246A (en) Implant for artificial dental root
Hench Physiological factors at bioceramic interfaces
Khan et al. Advanced Ceramics for Biomedical Applications
EP4671226A1 (en) STRUCTURE AND MANUFACTURING PROCESS FOR IT
JPH0622574B2 (en) Inorganic biomaterial and method for producing the same
JPH0352304B2 (en)
Reddy et al. Advanced Ceramics for Biomedical Applications
JPS60259268A (en) Artificial tubular organ
Barralet Processing and sintering of carbonate hydroxyapatite